Side effects are generally mild
Problemas cardiovasculares: los medicamentos con semaglutida podran reducir los accidentes cerebrovasculares y los ataques cardacos Un estudio realizado en agosto concluy que la semaglutida reduce en un 28% el riesgo de desarrollar enfermedades cardiovasculares como accidentes cerebrovasculares y ataques cardacos en personas con insuficiencia cardaca
Seek medical advice if fatigue: Persists beyond several months without improvement, despite adequate nutrition and hydration Worsens progressively or becomes debilitating, significantly impairing daily activities or work capacity Is accompanied by severe or persistent gastrointestinal symptoms (intractable nausea, vomiting, diarrhoea, abdominal pain) Occurs alongside signs of dehydration (dark urine, dizziness, reduced urine output, dry mouth) Is associated with symptoms of hypoglycaemia (tremor, sweating, confusion, palpitations), particularly in patients taking concurrent insulin or sulphonylureas Urgent medical attention is required if patients experience: Severe abdominal pain , especially if radiating to the back, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 medications
The margin for error is razor-thin: MT-1 activates melanocortin receptors (MC1R, MC3R, MC4R, MC5R) at specific concentration thresholds, and overshooting by even 0.2mg can trigger receptor-mediated side effects that derail research protocols entirely
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
